17-beta-estradiol
Ovulation Disorder
CRG UZ BrusselPhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Ovulation Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Gonadotropin-Releasing Hormone RenJi Hospital | Phase 4 | BB |
Spironolactone University of Virginia | Early Phase 1 | C |
Humulin R Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | D |
Same molecule, other indications
17-beta-estradiol is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →